We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Regression of Tumor Thrombus in the Suprahepatic Vena Cava of Hepatocellular Carcinoma and Conversion Hepatectomy Induced by Lenvatinib.
- Authors
Matsuki, Ryota; Okano, Naohiro; Arai, Takaaki; Yoshiike, Shinya; Kogure, Masaharu; Suzuki, Yutaka; Shibahara, Junji; Furuse, Junji; Sakamoto, Yoshihiro
- Abstract
Dear Editor, Recent developments in systemic therapy for hepatocellular carcinoma (HCC) have been outstanding, and a response rate of 40.6% based on the modified RECIST criteria has been reported after lenvatinib (LEN) therapy for advanced HCC [[1]]. Preoperative LEN therapy might be a promising option among the multidisciplinary treatments for HCC with macroscopic HVTT. CT, computed tomography; TT, tumor thrombus; LEN, lenvatinib; IVC, inferior vena cava.
- Subjects
VENAE cavae; HEPATOCELLULAR carcinoma; THROMBOSIS; HEPATECTOMY; BLOOD loss estimation
- Publication
Liver Cancer (2235-1795), 2022, Vol 11, Issue 3, p278
- ISSN
2235-1795
- Publication type
Article
- DOI
10.1159/000520822